Skip to main content
SpringerLink
Log in

Pathology of Esophageal Squamous Cell Carcinoma

  • Chapter
  • First Online:
Esophageal Squamous Cell Carcinoma

  • 485 Accesses

Abstract

Superficial esophageal cancers are classified into three major types including type 0-I (superficial and protruding type including type 0-Ip (pedunculated) and type 0-Is (sessile)), type 0-II (superficial and flat type including type 0-IIa (slightly elevated), type 0-IIb (flat) and type 0-IIc (slightly depressed)), and type 0-III (superficial and excavated type)). More protruded (type 0-I) or more depressed (type 0-III) lesions are associated with deeper invasion in the submucosa. All submucosal cancers have a substantial risk of lymph node metastases. Consequently, intraepithelial carcinoma or carcinoma invading the lamina propria is generally treated by endoscopic resection. Advanced esophageal cancers are classified into four types including type 1 (protruding type), type 2 (ulcerative and localized type), type 3 (ulcerative and infiltrative type), and type 4 (diffusely infiltrative type). The two most frequent types are Types 2 and 3. Iodine staining method is useful not only for optimal visualization of esophageal squamous mucosal abnormalities but also for detecting groups at high risk of multicentric cancer in the upper aerodigestive tract. Clinicopathologic prognostic factors include TNM stage, lymph node metastasis, tumor invasion depth, lympho-vascular invasion, intramural metastasis, tumor vascularity, infiltrating growth pattern, inflammatory response, tumor budding, tumor nest configuration, pathologic response to neoadjuvant therapy, completeness of surgical resection, and the patient’s general health condition. The subtypes of esophageal squamous cell carcinoma include basaloid squamous cell carcinoma, carcinosarcoma/spindle cell squamous cell carcinoma/sarcomatoid carcinoma, adenosquamous carcinoma, and verrucous carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Japan Esophageal Society. Japanese Classification of Esophageal Cancer, second English version. Tokyo: Kanehara; 2015.

    Google Scholar 

  2. Japan Esophageal Society. Japanese Classification of Esophageal Cancer, 11th edition: part 1. Esophagus. 2017;14:1–36.

    Google Scholar 

  3. Japan Esophageal Society. Japanese Classification of Esophageal Cancer, 11th edition: part II and III. Esophagus. 2017;14:37–65.

    Google Scholar 

  4. Odze RD, Cree IA, Klimstra DS, et al. WHO Classification of Tumours. Digestive System Tumours, fifth ed. Lyon: IARC press; 2019.

    Google Scholar 

  5. Amin MB, et al., editors. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017.

    Google Scholar 

  6. Brierley JD, Gospodarowicz MK, Wittekind C, editors. TNM Classification of Malignant Tumours, 8th ed. Wiley-Blackwell: Oxford; 2017.

    Google Scholar 

  7. Dawsey SM, Fleischer DE, Wang GQ, et al. Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer. 1998;83:220–31.

    Article  CAS  PubMed  Google Scholar 

  8. Mori M, Adachi Y, Matsushima T, et al. Lugol staining pattern and histology of esophageal lesions. Am J Gastroenterol. 1993;88:701–5.

    CAS  PubMed  Google Scholar 

  9. Nakanishi Y, Ochiai A, Shimoda T, et al. Epidermization in the esophageal mucosa: unusual epithelial changes clearly detected by Lugol’s staining. Am J Surg Pathol. 1997;21:605–9.

    Article  CAS  PubMed  Google Scholar 

  10. Nakanishi Y, Ochiai A, Yoshimura K, et al. The clinicopathologic significance of small areas unstained by Lugol’s iodine in the mucosa surrounding resected esophageal carcinoma: an analysis of 147 cases. Cancer. 1998;82:1454–9.

    Article  CAS  PubMed  Google Scholar 

  11. Park JY, Kim DM, Min BH, et al. Esophageal parakeratosis mimicking endoscopic appearance of superficial esophageal neoplastic lesion such as dysplasia. Dig Endosc. 2012;24:117–9.

    Article  PubMed  Google Scholar 

  12. Yoshikawa I, Yamasaki M, Yamasaki T, et al. Lugol chromoendoscopy as a diagnostic tool in so-called endoscopy-negative GERD. Gastrointest Endosc. 2005;62:698–703.

    Article  PubMed  Google Scholar 

  13. Boyce HW. Barrett esophagus. Endoscopic findings and what to biopsy. J Clin Gastroenterol. 2003;36(Suppl. 1):S6–S18.

    Article  PubMed  Google Scholar 

  14. Tachimori Y, Ozawa S, Numasaki H, et al. Comprehensive Registry of Esophageal Cancer in Japan, 2012. Esophagus. 2019;16:221–45.

    Google Scholar 

  15. Raza MA, Mazzara PF. Sarcomatoid carcinoma of esophagus. Arch Pathol Lab Med. 2011;135:945–8.

    PubMed  Google Scholar 

  16. Ide H, Ozawa S, Matsubara H, et al. Comprehensive Registry of Esophageal Cancer in Japan, 2000. Esophagus. 2009;6:27–47.

    Google Scholar 

  17. Participants in the Paris Workshop. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc. 2003;58(Suppl 6):S3–S43.

    Article  Google Scholar 

  18. Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery. 1998;123:432–9.

    Article  CAS  PubMed  Google Scholar 

  19. Takubo K. Pathology of the esophagus, third ed. Tokyo: Wiley; 2017.

    Google Scholar 

  20. Katada C, Muto M, Tanabe S, et al. Surveillance after endoscopic mucosal resection or endoscopic submucosal dissection for esophageal squamous cell carcinoma. Dig Endosc. 2013;25(Suppl 1):39–43.

    Article  PubMed  Google Scholar 

  21. Muto H, Hironaka S, Nakane M, et al. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Gastrointest Endosc. 2002;56:517–21.

    Google Scholar 

  22. Cui R, Kamatani Y, Takahashi A, et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology. 2009;137:1768–75.

    Article  CAS  PubMed  Google Scholar 

  23. Hirota WK, Zuckerman MJ, Adler DG, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63(4):570–80.

    Article  PubMed  Google Scholar 

  24. Islami F, Boffetta P, Ren JS, et al. High-temperature beverages and foods and esophageal cancer risk – a systemic review. Int J Cancer. 2009;125:491–524.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Morton LM, Gilbert ES, Hall P, et al. Risk of treatment-related esophageal cancer among breast cancer survivors. Ann Oncol. 2012;23:3081–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Anderson SR, Sinacori JT. Plummer-Vinson syndrome heralded by postcricoid carcinoma. Am J Otolaryngology. 2007;28:22–4.

    Article  Google Scholar 

  27. Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology. 2018;154:360–73.

    Article  PubMed  Google Scholar 

  28. Landgren AM, Landgren O, Gridley G, et al. Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million U.S. male veterans. Cancer. 2011;117:1163–71.

    Article  PubMed  Google Scholar 

  29. Chandan VS, Murray JA, Abraham SC. Esophageal lichen planus. Arch Pathol Lab Med. 2008;132:1026–9.

    PubMed  Google Scholar 

  30. Nakanishi Y, Ochiai A, Kato H, et al. Clinicopathological significance of tumor nest configuration in patients with esophageal squamous cell carcinoma. Cancer. 2001;91:1114–1120.

    Google Scholar 

  31. Lack E, Worsham F, Callihan M, et al. Granular cell tumor: a clinicopathologic study of 110 patients. J Surg Oncol. 1980;13:301–6.

    Article  CAS  PubMed  Google Scholar 

  32. Abraham S, Singh V, Yardley J, et al. Hyperplastic polyps of the esophagus and esophagogastric junction. Am J Surg Pathol. 2001;25:1180–7.

    Article  CAS  PubMed  Google Scholar 

  33. Rice TW, Zuccaro G, Adelstein DJ, et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg. 1998;65:787–92.

    Article  CAS  PubMed  Google Scholar 

  34. Weinberg JA. Lymphatics of the esophagus. In: Haagensen CD, Feind CR, Herter FP, Slanetz Jr CA, Weinberg JA, editors. The lymphatics in cancer. Saunders: Philadelphia; 1972.

    Google Scholar 

  35. Kitagawa Y, Uno T, Oyama T, et al. Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 2. Esophagus. 2019;16:25–43.

    Google Scholar 

  36. Nishimaki T, Tanaka O, Suzuki T, et al. Tumor spread in superficial esophageal cancer: histopathologic basis for rational surgical treatment. World J Surg. 1993;17:766–72.

    Article  CAS  PubMed  Google Scholar 

  37. Tajima T, Nakanishi Y, Tachimori Y, et al. Significance of involvement by squamous cell carcinoma of the ducts of esophageal submucosal glands. Cancer. 2000;89:248–54.

    Google Scholar 

  38. Chu P, Stagias J, West AB, et al. Diffuse pagetoid squamous cell carcinoma in situ of the esophagus. Cancer. 1997;79:1865–70.

    Article  CAS  PubMed  Google Scholar 

  39. Ishihara A, Mori T, Kono M. Diffuse pagetoid squamous cell carcinoma of the esophagus combined with choriocarcinoma and mucoepidermoid carcinoma: an autopsy case report. Path Int. 2002;53:147–52.

    Article  Google Scholar 

  40. Eguchi T, Nakanishi Y, Shimoda T, et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol. 2006;19:475–80.

    Article  PubMed  Google Scholar 

  41. Tajima Y, Nakanishi Y, Ochiai A, et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer. 2000;88:1285–93.

    Google Scholar 

  42. Kato H, Tachimori Y, Watanabe H, et al. Intramural metastasis of thoracic esophageal carcinoma. Int J Cancer. 1992;50:49–52.

    Article  CAS  PubMed  Google Scholar 

  43. Kuwano H, Nakajima M, Miyazaki T, et al. Distinctive clinicopathological characteristics in esophageal squamous cell carcinoma. Ann Thorac Cardiovasc Surg. 2003;9:6–13.

    PubMed  Google Scholar 

  44. Ide H, Nakamura T, Hayashi K, et al. Esophageal squamous cell carcinoma: pathology and prognosis. World J Surg. 1994;18:321–30.

    Article  CAS  PubMed  Google Scholar 

  45. Igaki H, Kato H, Tachimori Y, et al. Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection. Surgery. 2003;133:368–74.

    Article  PubMed  Google Scholar 

  46. Tanigawa N, Matsumura M, Amaya H, et al. Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer. 1997;79:220–5.

    Article  CAS  PubMed  Google Scholar 

  47. Sarbia M, Bittinger F, Porschen R, et al. Prognostic value of histopathologic parameters of esophageal squamous cell carcinoma. Cancer. 1995;76:922–7.

    Article  CAS  PubMed  Google Scholar 

  48. Schumacher K, Haensch W, Roefzaad C, et al. Prognostic significance of activated CD8+ T cell infiltration within esophageal carcinomas. Cancer Res. 2001;61:3932–6.

    CAS  PubMed  Google Scholar 

  49. Miyata H, Yoshioka A, Yamasaki M, et al. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. Cancer. 2009;115:3324–34.

    Article  PubMed  Google Scholar 

  50. Tanabe T, Kanda T, Kosugi S, et al. Extranodal spreading of esophageal squamous cell carcinoma: clinicopathological characteristics and prognostic impact. World J Surg. 2007;31:2192–8.

    Google Scholar 

  51. Sung CO, Park CK, Kim SH, et al. Classification of epithelial-mesenchymal transition phenotypes in esophageal squamous cell carcinoma is strongly associated with patient prognosis. Mod Pathol. 2011;24:1060–8.

    Article  PubMed  Google Scholar 

  52. Yamamoto M, Doki Y, Shiozaki H, et al. Evaluation of the histologic effect of chemoradiation therapy for squamous cell carcinomas of the esophagus by assessing morphologic features of surgical specimens. Dis Esophagus. 2000;13:293–300.

    Article  CAS  PubMed  Google Scholar 

  53. Takagawa R, Kunisaki C, Makino H, et al. Efficacy of chemoradiotherapy with low-dose cisplatin and continuous infusion of 5-fluorouracil for unresectable squamous cell carcinoma of the esophagus. Dis Esophagus. 2009;22:482–9.

    Article  PubMed  Google Scholar 

  54. Akutsu Y, Matsubara H. The significance of lymph node status as a prognostic factor for esophageal cancer. Surg Today. 2011;41:1190–5.

    Google Scholar 

  55. Shimada H, Okazumi S, Shiratori T, et al. Impact of lymph node involvement in T2 or T3 thoracic esophageal squamous cell carcinoma. Hepato-Gastroenterology. 2009;56:1039–43.

    PubMed  Google Scholar 

  56. Tachimori T, Nagai Y, Kanamori N, et al. Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system. Dis Esophagus. 2011;24:33–8.

    Article  CAS  PubMed  Google Scholar 

  57. Peyre CG, Hagen JA, DeMeester SR, et al. Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg. 2008;248:979–85.

    Article  PubMed  Google Scholar 

  58. Rizk N, Venkatraman E, Park B, et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer Staging System. J Thorac Cardiovasc Surg. 2006;132:1374–81.

    Google Scholar 

  59. Hao JJ, Lin DC, Dinh HQ, et al. Spatial intratumor heterogeneity of epigenetic alterations and temporal clonal evolution in esophageal squamous cell carcinoma. Nat Genet. 2016;48:1500–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Lin DC, Du XL, Wang MR. Protein alterations in esophageal squamous cell carcinoma and clinical implications: a review. Dis Esophagus. 2009;22:9–20.

    Article  PubMed  Google Scholar 

  61. Lin DC, Wang MR, Koeffler HP, et al. Genomic and epigenomic aberrations in esophageal squamous cell carcinoma and implications for patients. Gastroenterology. 2018;154:374–89.

    Article  PubMed  Google Scholar 

  62. Taylor PR, Abnet CC, Dawsey SM. Squamous dysplasia – the precursor lesion for esophageal squamous cell carcinoma. Cancer Epidemiol Biomark Prev. 2013;22:540–52.

    Article  Google Scholar 

  63. Itabashi M, Nasierowska-Guttmejer A, Shimoda T, et al. The importance of the concept and histological criteria of “intraepithelial squamous cell carcinoma” of the esophagus: in comparison between Western and Japanese criteria. Esophagus. 2017;14:333–42.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Schlemper RJ, Dawsey SM, Itabashi M, et al. Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists. Cancer. 2000;88:996–1006.

    Article  CAS  PubMed  Google Scholar 

  65. Wang WC, Wu TT, Chandan VS, et al. Ki-67 and ProEXC are useful immunohistochemical markers in esophageal squamous intraepithelial neoplasia. Hum Pathol. 2011;42:1430–7.

    Article  CAS  PubMed  Google Scholar 

  66. Mandard AM, Dalibard F, Mandard JC. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations. Cancer. 1994;73:2680–6.

    Article  CAS  PubMed  Google Scholar 

  67. Imamhasan A, Mitomi H, Saito T, et al. Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas. Hum Pathol. 2012;43:2012–23.

    Article  CAS  PubMed  Google Scholar 

  68. Kobayashi Y, Nakanishi Y, Taniguchi H, et al. Histological diversity in basaloid squamous cell carcinoma of the esophagus. Dis Esophagus. 2009;22:231–8.

    Article  CAS  PubMed  Google Scholar 

  69. Tripathi M, Swanson PE. Rare tumors of esophageal squamous mucosa. Ann N Y Acad Sci. 2016;1381:122–32.

    Article  PubMed  Google Scholar 

  70. Hishida T, Nakanishi Y, Shimoda T, et al. Esophageal basaloid carcinoma with marked myoepithelial differentiation. Pathol Int. 2002;52:313–7.

    Article  PubMed  Google Scholar 

  71. Sarbia M, Verreet P, Bittinger F, et al. Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis. Cancer. 1997;79:1871–8.

    Article  CAS  PubMed  Google Scholar 

  72. Ni PZ, Yang YS, Hu WP, et al. Primary adenosquamous carcinoma of the esophagus: an analysis of 39 cases. J Thorac Dis. 2016;8:2689–96.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Yachida S, Nakanishi Y, Shimoda T, et al. Adenosquamous carcinoma of the esophagus. Oncology. 2004;66:218–25.

    Article  PubMed  Google Scholar 

  74. Bombi JA, Riverola A, Bordas JM, et al. Adenosquamous carcinoma of the esophagus: a case report. Path Res Pract. 1991;187:514–9.

    Article  CAS  PubMed  Google Scholar 

  75. Chen SB, Weng HR, Wang G, et al. Primary adenosquamous carcinoma of the esophagus. World J Gastroenterol. 2013;19:8382–90.

    Google Scholar 

  76. Lam KY, Dickens P, Loke SL, et al. Squamous cell carcinoma of the esophagus with mucin-producing component (mucoepidermoid carcinoma and adenosquamous carcinoma): a clinicopathologic study and a review of literature. Eur J Surg Oncol. 1994;20:25–31.

    Google Scholar 

  77. Yendamuri S, Malhotra U, Hennon M, et al. Clinical characteristics of adenosquamous esophageal carcinoma. J Gastrointest Oncol. 2017;8:89–95.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Cappellesso R, Coati I, Barzon L, et al. Human papillomavirus infection is not involved in esophageal verrucous carcinoma. Hum Pathol. 2019;85:50–7.

    Article  PubMed  Google Scholar 

  79. Sweetser S, Jacobs NL, Song LM. Endoscopic diagnosis and treatment of esophageal verrucous squamous cell cancer. Dis Esophagus. 2014;27:452–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Moffitt Cancer Center, Tampa, Florida, USA

    Yukihiro Nakanishi

Authors
  1. Yukihiro Nakanishi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yukihiro Nakanishi .

Editor information

Editors and Affiliations

  1. International Goodwill Hospital, Yokohama, Japan

    Nobutoshi Ando

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nakanishi, Y. (2020). Pathology of Esophageal Squamous Cell Carcinoma. In: Ando, N. (eds) Esophageal Squamous Cell Carcinoma. Springer, Singapore. https://doi.org/10.1007/978-981-15-4190-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-4190-2_2

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-4189-6

  • Online ISBN: 978-981-15-4190-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation